These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9291715)

  • 21. Dyskinesias subside off all medication in a boy with autistic disorder and severe mental retardation.
    Brasić JR; Barnett JY; Aisemberg P; Ahn SC; Nadrich RH; Kaplan D; Ahmad R; Mendonça Mde F
    Psychol Rep; 1997 Dec; 81(3 Pt 1):755-67. PubMed ID: 9400068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential response of seven subjects with autistic disorder to clomipramine and desipramine.
    Gordon CT; Rapoport JL; Hamburger SD; State RC; Mannheim GB
    Am J Psychiatry; 1992 Mar; 149(3):363-6. PubMed ID: 1536276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosis associated with fluoxetine in Prader-Willi syndrome.
    Hergüner S; Motavalli Mukaddes N
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):944-945. PubMed ID: 17667473
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of acute intravenous clomipramine on obsessive-compulsive symptoms and response to chronic treatment.
    Mundo E; Bellodi L; Smeraldi E
    Biol Psychiatry; 1995 Oct; 38(8):525-31. PubMed ID: 8562664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
    Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
    J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism.
    Dartnall NA; Holmes JP; Morgan SN; McDougle CJ
    J Autism Dev Disord; 1999 Feb; 29(1):87-91. PubMed ID: 10097998
    [No Abstract]   [Full Text] [Related]  

  • 27. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
    Zohar J; Judge R
    Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomipramine-induced urinary retention in a cat.
    Pfeiffer E; Guy N; Cribb A
    Can Vet J; 1999 Apr; 40(4):265-7. PubMed ID: 10200885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sexual side-effects of clomipramine--a psychopharmacologic personal experience].
    Haberfellner EM
    Psychiatr Prax; 1996 May; 23(3):146. PubMed ID: 8711010
    [No Abstract]   [Full Text] [Related]  

  • 30. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD; Johnson BR; Lucas JP
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
    Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
    J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin Syndrome After an Alcohol Intake in a Patient Treated With Escitalopram and Clomipramine.
    Suzuki A; Otani K
    Clin Neuropharmacol; 2019; 42(3):103-104. PubMed ID: 30844852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapy of compulsive disorders in childhood and adolescence].
    Wewetzer Ch; Mehler-Wex C; Warnke A
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):223-30. PubMed ID: 12942794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does clomipramine in combination with alcohol provoke violent crimes?].
    Meyer L; Wiklund N; Lidberg L
    Lakartidningen; 1991 Aug; 88(35):2768-9. PubMed ID: 1895828
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Description and development of compulsive tail chasing in terriers and response to clomipramine treatment.
    Moon-Fanelli AA; Dodman NH
    J Am Vet Med Assoc; 1998 Apr; 212(8):1252-7. PubMed ID: 9569164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The serotonin syndrome as a learning opportunity.
    Brooks SA
    Can J Psychiatry; 1998 Aug; 43(6):646. PubMed ID: 9729697
    [No Abstract]   [Full Text] [Related]  

  • 39. Age onset subtypes of obsessive compulsive disorder: differences in clinical response to treatment with clomipramine.
    Ulloa RE; Nicolini H; Avila M; Fernández-Guasti A
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):85-96. PubMed ID: 17343556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.
    Koran LM; McElroy SL; Davidson JR; Rasmussen SA; Hollander E; Jenike MA
    J Clin Psychopharmacol; 1996 Apr; 16(2):121-9. PubMed ID: 8690827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.